About 363 results

ALLMedicine™ Extramedullary Plasmacytoma Center

Research & Reviews  139 results

Extramedullary plasmacytoma: Tumor occurrence and therapeutic concepts-A follow-up.
Cancer Medicine; Holler A, Cicha I et. al.

May 18th, 2022 - Extramedullary plasmacytoma (EMP) is a solitary tumor consisting of neoplastic plasma cells, with very little to no bone marrow involvement. EMPs are usually located in the head and neck region, but can also occur along the digestive tract, in lun...

Analysis of the Treatment and Survival of Sinonasal Extramedullary Plasmacytoma.
American Journal of Rhinology & Allergy; Gao J, Tseng CC et. al.

Apr 21st, 2022 - While extramedullary plasmacytomas are infrequently encountered plasma cell malignancies, most cases occur in the head and neck, with a predilection for the sinonasal cavity. Due to the rarity of this disease, the majority of studies on sinonasal ...

Extramedullary Plasmacytoma: Hepatic Lesions and Enlarged Lymph Nodes With Intense 18F-...
Clinical Nuclear Medicine; Wu F, Yu M et. al.

Mar 22nd, 2022 - A 66-year-old woman having intermittent abdominal distention for 2 months was referred to our hospital. An enhanced abdominal CT scan showed multiple hepatic lesions, suspected of metastases. An 18F-FDG PET/CT scan, which was performed to seek pri...

Bilateral Testicular Mass Presenting as a Rare Manifestation of Extramedullary Plasmacy...
Clinical Nuclear Medicine; Civan C, Apaydin Arikan E et. al.

Jan 14th, 2022 - We present the case of a 48-year-old man diagnosed with metastatic Ewing sarcoma who was referred for 18F-FDG PET/CT for treatment response evaluation following chemoradiotherapy. The patient also had complaints of new-onset testicular swelling at...

see more →

Guidelines  1 results

Consensus on Surgical Management of Myeloma Bone Disease.
Orthopaedic Surgery;

Sep 15th, 2016 - Myeloma bone disease (MBD), the skeletal lesions caused by multiple myeloma, is also known as skeletal related events and includes bone pain, osteoporosis, pathological fractures, osteolytic bone lesions, spinal instability, spinal cord and nerve ...

see more →

Clinicaltrials.gov  1 results

CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma

Jan 13th, 2015 - The purpose of this study is to determine whether Cyclophosphamide, Liposome doxorubicin and Dexamethasone(CDD) Plus Bortezomib might have effective in extramedullary plasmacytoma.

see more →

News  4 results

CAR T-Cell Therapy-Associated Toxicities Could Be Mitigated With Anakinra Prophylaxis in Multiple Myeloma

Jun 11th, 2021 - The incidence of grade ≥2 cytokine release syndrome (CRS) was lower in patients with relapsed or refractory multiple myeloma (RRMM) who received anakinra (Kineret) prophylaxis with orvacabtagene autoleucel (orva-cel), a B-cell maturation antigen (...

Severe Gingival Swelling and Erythema
Mohammed Bindakhil, DDS, Thomas P. Sollecito, DMD et. al.

Jun 16th, 2020 - The Diagnosis: Plasma Cell Gingivitis Microscopic analysis demonstrated an acanthotic stratified squamous epithelium with an edematous fibrous stroma containing dense perivascular infiltrates of plasma cells and lymphocytes (Figure 1). Immunohisto.

Extramedullary plasmacytoma of the thyroid, refractory to radiation therapy and treated with bortezomib
Ghimire et al

Aug 27th, 2018 - Plasma cell neoplasms involving tissues other than the bone marrow are known as extramedullary plasmacytoma (EMP). 1 EMPs mostly involve the head and neck region.

New criteria for diagnosing MM could prevent organ damage
HT Staff

Oct 29th, 2014 - Bone marrow biopsy Credit: Chad McNeeley The International Myeloma Working Group (IMWG) has published new criteria for diagnosing multiple myeloma (MM) in The Lancet Oncology. The group has added validated biomarkers to the current clinical sympto.

see more →